Ardea Biosciences, Inc. Contracts & Agreements

AGREEMENT AND PLAN OF MERGER among: ZENECA INC., a Delaware corporation, QAM CORP., a Delaware corporation, and ARDEABIOSCIENCES, INC. a Delaware corporation Dated as of April 21,... (Filed With SEC on April 24, 2012)

VOTING AGREEMENT (Filed With SEC on April 24, 2012)

8,500,000 Shares ARDEA BIOSCIENCES, INC. Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on February 6, 2012)

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS UNAUDITED (Filed With SEC on May 9, 2011)

Product Candidate (Filed With SEC on March 11, 2011)

Exhibit Number (Filed With SEC on January 21, 2011)

Current assets (Filed With SEC on November 9, 2010)

Current assets (Filed With SEC on August 6, 2010)

3,500,000 Shares (Filed With SEC on April 9, 2010)

Product Candidate (Filed With SEC on March 12, 2010)

Current assets (Filed With SEC on August 7, 2009)

Product Candidate (Filed With SEC on March 13, 2009)

Exhibit Number (Filed With SEC on December 22, 2008)

Exhibit Number (Filed With SEC on December 18, 2008)

Product candidate (Filed With SEC on March 24, 2008)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 10, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 20, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 20, 2007)

Document Description (Filed With SEC on July 3, 2007)

Current assets (Filed With SEC on May 8, 2007)

ASSET PURCHASE AGREEMENT (Filed With SEC on December 28, 2006)

Current assets (Filed With SEC on November 7, 2006)

INTRABIOTICS PHARMACEUTICALS, INC (Filed With SEC on June 29, 2006)

Risk Factors (Filed With SEC on February 21, 2006)

Current assets (Filed With SEC on July 21, 2005)

Current assets (Filed With SEC on May 12, 2005)

Legal Proceedings (Filed With SEC on March 10, 2005)

Other Expenses of Issuance and Distribution (Filed With SEC on April 22, 2004)

Other Expenses of Issuance and Distribution (Filed With SEC on April 14, 2004)

Common Stock and Warrant Purchase Agreement, dated October 6, 2003 (the Purchase Agreement) by and among the Company and each Investor as defined therein (Filed With SEC on October 9, 2003)

FINANCIAL INFORMATION (Filed With SEC on May 14, 2003)

FINANCIAL INFORMATION (Filed With SEC on November 14, 2002)

FINANCIAL INFORMATION (Filed With SEC on August 14, 2002)

2 AttachmentI Registration Rights (Filed With SEC on May 15, 2002)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on August 14, 2001)

INTRABIOTICS PHARMACEUTICALS,INC. Amended and Restated 1995 StockOption Plan Adopted February 15, 1995 Amended on June 13, 1996 Amended on July 29, 1997 Amended on October 21,... (Filed With SEC on August 14, 2001)

Attachment A Ramoplanin VRE Program Budget Analysis (from BI perspective of IBPI proposed aggreement) [*] (Filed With SEC on August 14, 2001)

FIRST AMENDMENT TO THE AGREEMENT BETWEEN INTRABIOTICS PHARMACEUTICALS,INC. AND ALBANY MOLECULAR RESEARCH, INC. FIRST AMENDMENT TO THE RESEARCH AND TECHNOLOGY AGREEMENT BETWEEN... (Filed With SEC on August 14, 2001)

INTRABIOTICSPHARMACEUTICALS, INC. SENIOREXECUTIVE SEVERANCE BENEFIT PLAN (Filed With SEC on August 14, 2001)

INTRABIOTICSPHARMACEUTICALS, INC. EXECUTIVESEVERANCE BENEFIT PLAN (Filed With SEC on August 14, 2001)

2001Officer Incentive Bonus Plan Summary (Filed With SEC on August 14, 2001)

RELEASE AGREEMENT (Filed With SEC on August 14, 2001)

WARRANT TO PURCHASE 700,000 SHARES OF COMMON STOCK OF INTRABIOTICS PHARMACEUTICALS, INC. (Void after July 27, 2005) (Filed With SEC on August 14, 2001)

DRUG DISCOVERY, DEVELOPMENT, AND LICENSE AGREEMENT by and between DIVERSA CORPORATION and INTRABIOTICS PHARMACEUTICALS, INC. (Filed With SEC on May 11, 2001)

RESEARCHAND TECHNOLOGY AGREEMENT (Filed With SEC on May 11, 2001)

Category

Industry

Companies

Contracts

Ardea Biosciences, Inc. Contracts & Agreements